Florence A. Arts
Brussels, BRU, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Epilepsy phenotype and developmental outcome in girls with mosaicism in X-linked neurodevelopmental disorders.
Journal: Epileptic disorders : international epilepsy journal with videotape
Published: March 11, 2025
Penttinen syndrome-associated PDGFRB Val665Ala variant causes aberrant constitutive STAT1 signalling.
Journal: Journal of cellular and molecular medicine
Published: February 11, 2022
PDGF receptor mutations in human diseases.
Journal: Cellular and molecular life sciences : CMLS
Published: October 07, 2020
Motor skills in children with strabismus.
Journal: Journal of AAPOS : the official publication of the American Association for Pediatric Ophthalmology and Strabismus
Published: October 07, 2019
Association of PDGFRB Mutations With Pediatric Myofibroma and Myofibromatosis.
Journal: JAMA dermatology
Published: April 25, 2019
miR-223 potentially targets SWI/SNF complex protein SMARCD1 in atypical proliferative serous tumor and high-grade ovarian serous carcinoma.
Journal: Human pathology
Published: July 14, 2017
Unwanted acquired mutations in Ba/F3 transformation assays.
Journal: Oncotarget
Published: April 21, 2017
PDGFRB gain-of-function mutations in sporadic infantile myofibromatosis.
Journal: Human molecular genetics
Published: February 09, 2017
A patient with germ-line gain-of-function PDGFRB p.N666H mutation and marked clinical response to imatinib.
Journal: Genetics in medicine : official journal of the American College of Medical Genetics
Published: February 06, 2017
PDGFRB mutants found in patients with familial infantile myofibromatosis or overgrowth syndrome are oncogenic and sensitive to imatinib.
Journal: Oncogene
Published: May 15, 2015
Idiopathic basal ganglia calcification-associated PDGFRB mutations impair the receptor signalling.
Journal: Journal of cellular and molecular medicine
Published: June 03, 2014
The tyrosine phosphatase SHP2 is required for cell transformation by the receptor tyrosine kinase mutants FIP1L1-PDGFRα and PDGFRα D842V.
Journal: Molecular oncology
Published: November 28, 2013
Showing 1-12 of 12
Last Updated: 09/26/2026